|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Gross loss | ||
| Operating expenses: | ||
| Research and development | ||
| Selling, general and administrative | ||
| Total costs and expenses | ||
| Total operating expenses | ||
| Loss from operations | ||
| Change in fair value of related party convertible loan | ||
| Gain on loan extinguishment | ||
| Interest income | ||
| Other income (expense), net | ||
| Loss before provision for income taxes | ||
| Provision for income taxes | ||
| Net loss attributable to noncontrolling interests | ||
| Net loss | ||
| Accretion of redeemable convertible preferred stock | ||
| Deemed dividend on exchange of Series A-2 redeemable convertible preferred stock for common stock | ||
| Net loss attributable to common stockholders, basic | ||
| Net loss attributable to common stockholders, diluted | ||
| Net loss per share attributable to common stockholders, basic (in dollars per share) | ||
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | ||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) | ||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) |
Loading...
